Navigation Links
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
Date:6/12/2008

tained clinical effect in belimumab-treated patients from Week 52 to Week 160 includes:

-- An increase from 46% to 52% among serologically active patients based

on the combined response rate selected as the primary efficacy endpoint

of the Phase 3 trials (intention-to-treat analysis).

-- A decrease over time in the overall frequency of SLE disease flares,

and in the frequency of severe disease flares, in patients who remained

on belimumab through three years, as measured by the SELENA SLEDAI

flare index.

-- A greater proportion of patients in the belimumab group reduced their

prednisone dose from baseline compared with the placebo group in the

double-blind phase of the study, and this number continued to increase

through three years.

-- Reversion of autoantibody levels from positive to negative

(anti-dsDNA, anti-RNP, anti-Smith).

-- Stable reductions in immunoglobulins, with no increase in infections or

infectious events over time.

-- An increase in C3 and C4 complement among patients with low complement

at baseline.

About the Phase 2 Study of LymphoStat-B in SLE

The primary objectives of the Phase 2 study were to evaluate the efficacy and safety of belimumab (LymphoStat-B) plus standard of care, versus placebo plus standard of care. A total of 449 patients with active SLE were randomized to receive one of three different doses of belimumab or placebo (1, 4 or 10 mg/kg) administered intravenously over a 52-week treatment period, in addition to standard-of-care therapy. At the end of 52 weeks, 345 patients chose to participate in an optional 24-week extension phase of the study, during which all patients received belimumab. At Week 76, 296 patients chose to remain on belimumab treatment in an open-label long-term continuation phase of the Phase 2 trial, in which all patients are receiving 10 mg/kg belimumab. As o
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
2. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
3. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
4. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
5. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
6. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
7. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
8. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
9. First Human Implant of New Archus Orthopedics Facet Replacement System
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Conn. , Sept. 19, 2014 UBM ... , a leading online community to help oncologists and ... information available regarding the use of targeted therapies and ... cancer research and treatment.  Every September, ... a way to raise awareness about blood cancers—helping to ...
(Date:9/19/2014)... , Sept. 19, 2014  Pressure BioSciences, Inc. ... it has received and approved all parts required ... and has begun to manufacture the new PCT-based ... will be ready for shipment by mid-October and ... released at a rate of about one per ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
... The Hanger Ivan R. Sabel Foundation today announced it ... Grapes for Humanity/US, an internationally recognized charitable foundation that has ... innocent victims of conflict and disease around the world.  The ... Foundation to continue its charitable efforts at its prosthetic clinic ...
... July 12 Ferring Pharmaceuticals Inc., the makers of ... Bat for the Cure charity, in an effort to "strike-out ... the organization,s Minor League Baseball initiative across the country. FIRMAGON® is ... , , ...
Cached Medicine Technology:Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 3Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 4
(Date:9/20/2014)... iFitDress.com, the popular online supplier of wedding dresses and ... new collection of cocktail gowns. This afternoon, the company ... new outfits; it intends to expand its online market ... cheap cocktail dresses in the company’s online ... extensive experience in the industry of women’s special occasion ...
(Date:9/20/2014)... September 20, 2014 "As a nurse, patients ... tanks," said an inventor from Tamaqua, Pa. "The reason that ... the backs of their chairs. My invention enables them to ... Kam Oxygen Sensor to make it easier to monitor the ... user knows when the tank is low. It allows changeovers ...
(Date:9/20/2014)... QueenBeeTickets.com is ready to offer discount Ariana Grande ... visit many cities in North America next year from ... , Click Here to view the inventory ... The star’s fans are not going to want to ... in a live performance. Ariana Grande concert tickets are ...
(Date:9/20/2014)... OH (PRWEB) September 20, 2014 The ... lawsuit is now in its third week in the ... Schulte LLC reports. Court documents indicate that the week ... with testimony from a DePuy Orthopaedics vice president, ... version of the company’s Pinnacle hip replacement. According to ...
(Date:9/19/2014)... OH (PRWEB) September 20, 2014 Nearly ... Court of Common Pleas where a meeting took place ... side-effects complaints pending in the court’s mass tort ... to meet this past week at the Complex Litigation ... are consolidated for pretrial proceedings. The Risperdal lawsuits filed ...
Breaking Medicine News(10 mins):Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4
... PROVIDENCE, RI Does obesity tend to "cluster" among ... have on both their weight and weight-related behaviors? That,s ... Diabetes Research Center set out to answer to better ... weight loss intentions in this difficult-to-reach age group. ...
... According to the World Health Organization (WHO), chronic diseases are ... representing 60% of all deaths worldwide and imposing an enormous ... whole. With its ageing population, Europe is bracing ... next decade. "We are pleased that the Council ...
... of an ectopic pregnancy because of a lasting effect of ... first time of how chlamydia can increase the risk of ... outside the womb, in the Fallopian tube. Researchers at ... the sexually transmitted infection were more likely to produce a ...
... January 2011: With its spotlight theme of ,Controversial ... Society of Cardiology (ESC) Congress promises lively discussions and ... as the world,s premier cardiovascular conference and regularly attracts ... through its doors. It will be held this ...
... By Steven Reinberg HealthDay Reporter , MONDAY, Jan. 10 ... in front of a computer may increase your risk for heart ... In fact, if you spend four hours a day or ... playing video games, you are more than two times more likely ...
... 11 (HealthDay News) -- Intensive care unit (ICU) patients in ... shared rooms, a new study finds. About 30 percent ... lead to serious illness and death, the study authors noted ... these infections are associated with an increased length of stay ...
Cached Medicine News:Health News:Family, friends, social ties influence weight status in young adults 2Health News:A new era for chronic diseases in Europe? 2Health News:Countdown to Paris and ESC Congress 2011 2Health News:Countdown to Paris and ESC Congress 2011 3Health News:Too Much TV May Be Linked to Heart Attack, Death Risk 2Health News:Too Much TV May Be Linked to Heart Attack, Death Risk 3Health News:Private Rooms Cut Infection Risk in the ICU: Study 2
The UNI_CLIP® is a reliable and stable compression staple....
... Indications include painful arthritic deformity ... in the subtalar joint, failed fusion ... the tibial plafond and/or talus where ... the ankle joint combined with severe ...
... System from DePuy is the first total ... of support that bridges the fused tibiofibular ... distribution. The Agility Ankle, developed in conjunction ... allow for normal alignment during the stance ...
... the key clinical and economic issues of ... is designed to maximize tension control while ... system combines efficient instrumentation with a simple ... system is indicated for general orthopaedic trauma ...
Medicine Products: